Repsol invests in DARWIN and transfers an innovative biotechnology solutio 20/02/2025 Healthcare Innovative drugs Talento Repsol, through its investment arm Repsol Corporate Venturing, has acquired a 21.43% stake in DARWIN Bioprospecting... Partners
ORYZON announces journal publication of final Phase IIa REIMAGINE results with vafidemstat... 14/02/2025 Healthcare Innovative drugs The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in... Partners - Oryzon Genomics
EIB finances with €15 million Amadix to develop innovative diagnostic tests for early canc... 11/02/2025 Healthcare Innovative drugs Advanced therapies EU projects Financing Amadix is a Spanish biotech company developing non-invasive blood tests for early detection of several types of cancer... Partners - Amadix
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non... AseBio - BATEA ONCOLOGY S.L.
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 BATEA ONCOLOGY S.L. It will also be necessary to develop therapies with fewer side effects, allowing the combination of different treatments... AseBio - BATEA ONCOLOGY S.L.
Pharmacovigilance training VI edition, Barcelona & Online 12-13 May 2025 30/01/2025 Healthcare Innovative drugs Partners - PVpharm
ORYZON announces first patient dosed in an Investigator-initiated Phase I study of iadadem... 23/01/2025 Healthcare Innovative drugs Study led by Medical College of Wisconsin and exploring the combination with azacitidine. Partners - Oryzon Genomics
ORYZON announces first patient dosed in NCI-sponsored iadademstat in combination with vene... 13/01/2025 Healthcare Innovative drugs Study conducted under the CRADA agreement between NCI and Oryzon. Partners - Oryzon Genomics
iDR25 Medicines Reimagined: Unlocking the potential of existing drugs for patient benefit Amsterdam Netherlands Del 07/05/2025 to 08/05/2025 Healthcare Innovative drugs
Nanobots Therapeutics advances its development after securing the first million in its see... 18/12/2024 Healthcare Innovative drugs Personalized medicine Financing The startup successfully completed the first stage of its seed investment round, raising €960,000 in private capital. Partners
